Literature DB >> 25979010

Noncoplanar VMAT for nasopharyngeal tumors: Plan quality versus treatment time.

Esther Wild1, Mark Bangert1, Simeon Nill2, Uwe Oelfke3.   

Abstract

PURPOSE: The authors investigated the potential of optimized noncoplanar irradiation trajectories for volumetric modulated arc therapy (VMAT) treatments of nasopharyngeal patients and studied the trade-off between treatment plan quality and delivery time in radiation therapy.
METHODS: For three nasopharyngeal patients, the authors generated treatment plans for nine different delivery scenarios using dedicated optimization methods. They compared these scenarios according to dose characteristics, number of beam directions, and estimated delivery times. In particular, the authors generated the following treatment plans: (1) a 4π plan, which is a not sequenced, fluence optimized plan that uses beam directions from approximately 1400 noncoplanar directions and marks a theoretical upper limit of the treatment plan quality, (2) a coplanar 2π plan with 72 coplanar beam directions as pendant to the noncoplanar 4π plan, (3) a coplanar VMAT plan, (4) a coplanar step and shoot (SnS) plan, (5) a beam angle optimized (BAO) coplanar SnS IMRT plan, (6) a noncoplanar BAO SnS plan, (7) a VMAT plan with rotated treatment couch, (8) a noncoplanar VMAT plan with an optimized great circle around the patient, and (9) a noncoplanar BAO VMAT plan with an arbitrary trajectory around the patient.
RESULTS: VMAT using optimized noncoplanar irradiation trajectories reduced the mean and maximum doses in organs at risk compared to coplanar VMAT plans by 19% on average while the target coverage remains constant. A coplanar BAO SnS plan was superior to coplanar SnS or VMAT; however, noncoplanar plans like a noncoplanar BAO SnS plan or noncoplanar VMAT yielded a better plan quality than the best coplanar 2π plan. The treatment plan quality of VMAT plans depended on the length of the trajectory. The delivery times of noncoplanar VMAT plans were estimated to be 6.5 min in average; 1.6 min longer than a coplanar plan but on average 2.8 min faster than a noncoplanar SnS plan with comparable treatment plan quality.
CONCLUSIONS: The authors' study reconfirms the dosimetric benefits of noncoplanar irradiation of nasopharyngeal tumors. Both SnS using optimized noncoplanar beam ensembles and VMAT using an optimized, arbitrary, noncoplanar trajectory enabled dose reductions in organs at risk compared to coplanar SnS and VMAT. Using great circles or simple couch rotations to implement noncoplanar VMAT, however, was not sufficient to yield meaningful improvements in treatment plan quality. The authors estimate that noncoplanar VMAT using arbitrary optimized irradiation trajectories comes at an increased delivery time compared to coplanar VMAT yet at a decreased delivery time compared to noncoplanar SnS IMRT.

Entities:  

Mesh:

Year:  2015        PMID: 25979010     DOI: 10.1118/1.4914863

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  Dosimetric accuracy of dynamic couch rotation during volumetric modulated arc therapy (DCR-VMAT) for primary brain tumours.

Authors:  Gregory Smyth; Philip M Evans; Jeffrey C Bamber; Henry C Mandeville; A Rollo Moore; Liam C Welsh; Frank H Saran; James L Bedford
Journal:  Phys Med Biol       Date:  2019-04-05       Impact factor: 3.609

2.  Optimization approaches to volumetric modulated arc therapy planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; David Craft; Markus Alber; Mark Bangert; Rasmus Bokrantz; Danny Chen; Ruijiang Li; Lei Xing; Chunhua Men; Simeon Nill; Dávid Papp; Edwin Romeijn; Ehsan Salari
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

3.  A novel optimization framework for VMAT with dynamic gantry couch rotation.

Authors:  Qihui Lyu; Victoria Y Yu; Dan Ruan; Ryan Neph; Daniel O'Connor; Ke Sheng
Journal:  Phys Med Biol       Date:  2018-06-13       Impact factor: 3.609

4.  Comparison of non-coplanar optimization of static beams and arc trajectories for intensity-modulated treatments of meningioma cases.

Authors:  Tiago Ventura; Humberto Rocha; Brigida da Costa Ferreira; Joana Dias; Maria do Carmo Lopes
Journal:  Phys Eng Sci Med       Date:  2021-10-07

5.  Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.

Authors:  Jenny Bertholet; Paul-Henry Mackeprang; Silvan Mueller; Gian Guyer; Hannes A Loebner; Yanick Wyss; Daniel Frei; Werner Volken; Olgun Elicin; Daniel M Aebersold; Michael K Fix; Peter Manser
Journal:  Radiat Oncol       Date:  2022-07-15       Impact factor: 4.309

6.  The development and verification of a highly accurate collision prediction model for automated noncoplanar plan delivery.

Authors:  Victoria Y Yu; Angelia Tran; Dan Nguyen; Minsong Cao; Dan Ruan; Daniel A Low; Ke Sheng
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

7.  A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy.

Authors:  Yaqin Wu; Biqing Zhu; Jingjing Han; Hanzi Xu; Zhen Gong; Yongqin Yang; Jian Huang; Emei Lu
Journal:  Ann Transl Med       Date:  2019-11

8.  Verification of the delivered patient radiation dose for non-coplanar beam therapy.

Authors:  Ivan Kutuzov; Timothy Van Beek; Boyd M C McCurdy
Journal:  J Appl Clin Med Phys       Date:  2021-05-22       Impact factor: 2.102

9.  Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy.

Authors:  Hideaki Hirashima; Mitsuhiro Nakamura; Yuki Miyabe; Megumi Uto; Kiyonao Nakamura; Takashi Mizowaki
Journal:  Radiat Oncol       Date:  2018-02-14       Impact factor: 3.481

10.  Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc.

Authors:  Manuela Burghelea; Dirk Verellen; Kenneth Poels; Cecilia Hung; Mitsuhiro Nakamura; Jennifer Dhont; Thierry Gevaert; Robbe Van den Begin; Christine Collen; Yukinori Matsuo; Takahiro Kishi; Viorica Simon; Masahiro Hiraoka; Mark de Ridder
Journal:  Radiat Oncol       Date:  2016-04-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.